Pioneering a new approach to biological discovery
IPI blends academic exploration with industrial scalability
to tap the full potential of recombinant antibodies.
Our proteins power discovery
IPI is a nonprofit research hybrid that invests in high-throughput technologies and deep protein expertise to bring biological research up to speed.
IPI in brief
![Drawing Of Microscope.](https://3j108d.a2cdn1.secureserver.net/wp-content/uploads/2021/08/home_discoveries-75x83.png)
Meeting research needs
IPI scientists deploy cutting-edge technologies and techniques, such as antibody engineering and a yeast display library, to tap the full potential of synthetic recombinant antibodies.
![Basic Drawing Of Antibody.](https://3j108d.a2cdn1.secureserver.net/wp-content/uploads/2021/08/home_antibodies-75x83.png)
Best of both worlds
IPI combines deep academic expertise with industrial scalability, investing in high-throughput technologies and automation to bring biological research up to speed.
![Figure Representing Business Model.](https://3j108d.a2cdn1.secureserver.net/wp-content/uploads/2021/08/home_businessmodel-75x83.png)
Unique business model
IPI is a nonprofit institute with assured funding and the high-caliber expertise to support exploratory protein research.
![Drawing Of Lightbulb.](https://3j108d.a2cdn1.secureserver.net/wp-content/uploads/2021/08/home_insight-75x83.png)
Cross-disciplinary connections
IPI is poised to elevate life science communities, collaborating with biologists across specialties and training young scientists.
Building collaborations
IPI believes the best science crosses fields. We draw together multiple disciplines to build antigen and antibody tools for basic biological research and therapeutic discovery.
Bespoke high-throughput approach expedites screening of cell-surface ectodomains
Cell-surface receptors are notoriously tricky to produce and purify; they misfold, aggregate, degrade, and often express poorly. Researchers can get past these roadblocks by focusing on...
Panel highlights antibody characterization and validation strategies
Biology’s shortage of high-quality, well-performing and easily accessible antibodies is no breaking news; it’s a challenge that has been painfully experienced and well-documented for years. Many...
Youssef Atef AbdelAlim carries protein science lessons to medical school
For IPI research associate Youssef Atef AbdelAlim, science is synonymous with patient care. He’s run antibody discovery sorts, engineered protein libraries and performed fluorescence microscopy. He’s...
Innovation comes naturally to IPI’s director of automation Curtis Walton
When Curtis Walton was young, he’d disassemble household items, diligently learning about their inner mechanisms as he reassembled them. Growing up in Sarnia, Ontario, he pulled...